| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biology (L.R., P.C.-O., Y.C., T.S., P.O.) and Division of Bone and Mineral Research (P.C.-O., Y.C., L.C., L.A., P.O.), Washington University, St. Louis, Missouri 63130; and the Department of Rheumatology (A.T., S.G.), Harvard Institutes of Medicine, Boston, Massachusetts 02115
Address all correspondence and requests for reprints to: Dr. Philip Osdoby, Department of Biology, Box 1229, Washington University, St. Louis, Missouri 63130. E-mail: osdoby{at}biodec.wustl.edu
Chemokines, including interleukin-8 (IL-8), function as key mediators
in diverse inflammatory disorders via promoting the recruitment,
proliferation, and activation of vascular and immune cells. IL-8 levels
are elevated in inflammatory diseases, such as rheumatoid arthritis,
osteoarthritis, osteomyelitis, and periodontal disease, that also
exhibit progressive bone loss. Therefore, it is possible that IL-8
contributes to the osteopenia associated with these pathological
conditions. Although macrophages, neutrophils, and endothelial cells
are considered the primary sources of inflammation-induced IL-8
increases, we report here for the first time that human bone
marrow-derived osteoclast-like cells (hOCL) as well as authentic
bone-resorbing human osteoclasts (hOC) isolated from osteoporotic
femoral heads express messenger RNA (mRNA) for IL-8 and secrete high
levels of IL-8 during culture. Basal IL-8 release by cultured hOC or
hOCL was orders of magnitude greater than the release of the
proinflammatory cytokines IL-1ß, IL-6, and tumor necrosis factor-
.
At a cellular level, in situ hybridization analysis
revealed that IL-8 mRNA was expressed in resorbing hOC of rheumatoid
arthritic pannus and was substantially greater than that expressed in
hOC of noninflammatory giant cell tumor of bone tissue. Therefore, the
potential inflammation-mediated induction of IL-8 was directly assessed
using cultured hOCL. IL-8 release was stimulated by proinflammatory
signals (IL-1
, tumor necrosis factor-
, lipopolysaccharide, or
phorbol 12-myristate 13-acetate), unaffected by various other
osteotropic modulators (transforming growth factor-ß1 and -ß3,
IL-6, 17ß-estradiol, or calcitonin) and was decreased by
interferon-
, vitamin D3, and the antiinflammatory
glucocorticoid dexamethasone. Changes in IL-8 secretion were paralleled
by corresponding changes in IL-8 mRNA steady state levels. We conclude
that hOC and hOCL synthesize and secrete high constitutive and
inflammation-stimulated levels of the chemokine IL-8. Consequently,
hOC-derived IL-8 could act as an important regulatory signal for bone,
vascular, and immune cell recruitment and activation during normal and
pathological bone remodeling.
This article has been cited by other articles:
![]() |
D. Onan, E. H. Allan, J. M. W. Quinn, J. H. Gooi, S. Pompolo, N. A. Sims, M. T. Gillespie, and T. J. Martin The Chemokine Cxcl1 Is a Novel Target Gene of Parathyroid Hormone (PTH)/PTH-Related Protein in Committed Osteoblasts Endocrinology, May 1, 2009; 150(5): 2244 - 2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lorenzo, M. Horowitz, and Y. Choi Osteoimmunology: Interactions of the Bone and Immune System Endocr. Rev., June 1, 2008; 29(4): 403 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoneda, N. Ishimaru, R. Arakaki, M. Kobayashi, T. Izawa, K. Moriyama, and Y. Hayashi Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with Receptor Activator of Nuclear Factor-{kappa}B Ligand-Mediated Osteoclastogenesis Endocrinology, May 1, 2004; 145(5): 2384 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
A S Taha, V Grant, and R W Kelly Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases Postgrad. Med. J., March 1, 2003; 79(929): 159 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Cottler-Fox, T. Lapidot, I. Petit, O. Kollet, J. F. DiPersio, D. Link, and S. Devine Stem Cell Mobilization Hematology, January 1, 2003; 2003(1): 419 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gurlek, M. R. Pittelkow, and R. Kumar Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation Endocr. Rev., December 1, 2002; 23(6): 763 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bendre, D. Gaddy-Kurten, T. Mon-Foote, N. S. Akel, R. A. Skinner, R. W. Nicholas, and L. J. Suva Expression of Interleukin 8 and not Parathyroid Hormone-related Protein by Human Breast Cancer Cells Correlates with Bone Metastasis in Vivo Cancer Res., October 1, 2002; 62(19): 5571 - 5579. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. N. Das Nitric Oxide as the Mediator of the Antiosteoporotic Actions of Estrogen, Statins, and Essential Fatty Acids Experimental Biology and Medicine, February 1, 2002; 227(2): 88 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Masood, S. Nagpal, T. Zheng, J. Cai, A. Tulpule, D. L. Smith, and P. S. Gill Kaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist Blood, November 1, 2000; 96(9): 3188 - 3194. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schierano, F. Bassi, G. Gassino, K. Mareschi, G. Bellone, and G. Preti Cytokine Production and Bone Remodeling in Patients wearing Overdentures on Oral Implants Journal of Dental Research, September 1, 2000; 79(9): 1675 - 1682. [Abstract] [PDF] |
||||
![]() |
P. Collin-Osdoby, L. Rothe, F. Anderson, M. Nelson, W. Maloney, and P. Osdoby Receptor Activator of NF-kappa B and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis J. Biol. Chem., June 1, 2001; 276(23): 20659 - 20672. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |